Marc Robillard, PhD
CEO and Founder
Dr. Robillard initiated and led the team working on Tagworks’ In Vivo Chemistry within Philips Research from 2006 until the spinout end of 2011. In 2003, he joined Philips Research to define and initiate their molecular medicine program in conjunction with the building of the corresponding laboratory facilities. As senior scientist and project leader he was involved in several imaging and drug delivery projects before creating the In Vivo Chemistry technology. Prior to Philips he worked at Kreatech Diagnostics on the development of a portfolio of probes for drug targeting and microarray-based detection of DNA, RNA and proteins. In addition he was a visiting scientist at the School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, and he worked at the CRO Syncom as a synthetic chemist. Dr. Robillard obtained his MSc and PhD in bio(in)organic chemistry at, respectively, the University of Groningen and the Leiden Institute of Chemistry, The Netherlands. He has published 19 peer-reviewed papers and is a co-inventor on 18 patents.
Raffaella Rossin, PhD
CSO and Founder
Dr. Rossin is responsible for the development of antibody derivatives and in vitro and in vivo studies. She has longstanding experience in radiolabeling and in vitro/in vivo testing of small molecules, antibodies and nanoparticles. From 2008-2015, Dr. Rossin worked as senior radiochemist at Philips Research, with primary focus on molecular imaging and drug delivery projects. In this role, she has been instrumental in developing the In Vivo Chemistry program that now forms the basis of Tagworks Pharmaceuticals. Prior to the position at Philips, she worked for almost 5 years at the School of Medicine of Washington University, St. Louis MO, as a post-doctoral research associate and as a research instructor in radiochemistry and nuclear imaging. Dr. Rossin obtained her MSc in organic chemistry and PhD in radiochemistry at the University of Padova, Italy. In addition she was a visiting scientist at the School of Chemistry, University of Bangor, Wales, and at the Paul Scherrer Institute, Villigen, Switzerland. She has published 40 peer-reviewed papers and is a co-inventor on 8 patents.